In defence of polypharmacy

Br J Clin Pharmacol. 2004 Feb;57(2):119-20. doi: 10.1111/j.1365-2125.2004.02067.x.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Drug Interactions
  • Drug Resistance
  • Drug-Related Side Effects and Adverse Reactions
  • Humans
  • Polypharmacy*
  • Treatment Outcome